Generation of glucocorticoid resistant SARS-CoV-2 T-cells for adoptive cell therapy

Adoptive cell therapy with viral-specific T cells has been successfully used to treat life-threatening viral infections, supporting the application of this approach against COVID-19. We expanded SARS-CoV-2 T-cells from the peripheral blood of COVID-19-recovered donors and non-exposed controls using...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:bioRxiv
Main Authors: Basar, Rafet, Uprety, Nadima, Ensley, Emily, Daher, May, Klein, Kimberly, Martinez, Fernando, Aung, Fleur, Shanley, Mayra, Hu, Bingqian, Gokdemir, Elif, Mendt, Mayela, Silva, Francia Reyes, Acharya, Sunil, Laskowski, Tamara, Muniz-Feliciano, Luis, Banerjee, Pinaki, Li, Ye, Li, Sufang, Garcia, Luciana Melo, Lin, Paul, Shaim, Hila, Yates, Sean G., Marin, David, Kaur, Indreshpal, Rao, Sheetal, Mak, Duncan, Lin, Angelique, Miao, Qi, Dou, Jinzhuang, Chen, Ken, Champlin, Richard, Shpall, Elizabeth J., Rezvani, Katayoun
Formato: Artigo
Idioma:Inglês
Publicado em: Cold Spring Harbor Laboratory 2020
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC7523118/
https://ncbi.nlm.nih.gov/pubmed/32995792
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1101/2020.09.15.298547
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados